RDHL · ISSUER CIK 1553846
RedHill Biopharma Ltd.
Between Aug 1, 2026 and Oct 29, 2026, 1 RedHill Biopharma Ltd. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202607:00 | Oct 1, 2026 | RDHL | Chief Operating Officer | S · SellPrice unverifiedLate 5d | $0.00 | −14,310,000 | 176,910,000 | -7% | — |